A phase II study of KN046 monotherapy as 2nd line and above treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).

被引：0
|
作者：
Gang, Jin
Guo, Shiwei
Zhang, Yanqiao
Ma, Yue
Guo, Xiaodong
Zhou, Xiaocui
Yu, Qin
机构：
[1] Navy Med Univ Second Mil Med Univ, Changhai Hosp, Dept Hepatobiliary Pancreat Surg, Shanghai, Peoples R China
[2] Harbin Med Univ Canc Hosp, Gastroenterol, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Heilongjiang, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16305
引用
收藏
页码：E16305 / E16305
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of KN046 plus nab-paclitaxel/gemcitabine as first-line treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
    Jin, Gang
    Guo, Shiwei
    Zhang, Yanqiao
    Ma, Yue
    Guo, Xiaodong
    Zhou, Xiaocui
    Yu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] The preliminary efficacy and safety of KN026 combined with KN046 treatment in HER2-positive locally advanced unresectable or metastatic gastric/gastroesophageal junction cancer without prior systemic treatment in a phase II study
    Shen, L.
    Gong, J.
    Niu, Z.
    Zhao, R.
    Chen, L.
    Liu, L.
    Deng, T.
    Lu, L.
    Zhang, Y.
    Li, Z.
    Li, X.
    Xia, B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1102 - S1102
  • [3] A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma
    Marsh, Robert de W.
    Lima, C. M. Rocha
    Levy, D. E.
    Mitchell, E. P.
    Rowland, K. M., Jr.
    Benson, A. B., III
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (01): : 26 - 31
  • [4] Efficacy and safety of KN026 in combination with KN046 in patients with locally advanced unresectable or metastatic HER2-positive other solid tumors
    Gong, Jifang
    Chen, Lei
    Sun, Meili
    Ni, Mingli
    Zhao, Rusen
    Wang, Xiangcai
    Ying, Jieer
    Zhang, Yanming
    Zhuang, Zhi-Xiang
    Li, Xionghui
    Lv, Yuan
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Efficacy and safety of KN046 plus paclitaxel/cisplatin as first-line treatment for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC).
    Xu, Jianming
    Liu, Rongrui
    Zhang, Yanqiao
    Xu, Nong
    Fan, Qingxia
    Gao, Shegan
    Pan, Hongming
    Cai, Mingquan
    Yan, Dong
    Liang, Qianqian
    Wu, Qiong
    Guo, Baohong
    Qi, Yakun
    Xu, Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Preliminary safety and efficacy results of KN046 in combination with KN026 in patients with locally advanced unresectable or metastatic HER2-positive solid cancer
    Gong, Jifang
    Chen, Lei
    Sun, Meili
    Zhang, Yanming
    Ying, Jieer
    Wang, Xiangcai
    Ni, Mingli
    Zhuang, Zhixiang
    Guo, Baohong
    Xiao, Long
    Xia, Summer
    Shen, Lin
    CANCER RESEARCH, 2022, 82 (12)
  • [7] A phase II study of abemaciclib as a monotherapy and in combination with other agents in patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC).
    Chiorean, E. Gabriela
    Hochster, Howard S.
    Nanda, Shivani
    Thornton, Donald
    Klise, Suzanne
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma
    Bullock, Andrea
    Stuart, Keith
    Jacobus, Susanna
    Abrams, Thomas
    Wadlow, Raymond
    Goldstein, Michael
    Miksad, Rebecca
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (06) : 945 - +
  • [9] A phase I/II study combining tosedostat with capecitabine in patients with metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wang-Gillam, Andrea
    Du, Lingling
    Teague, Andrea S.
    Suresh, Rama
    Lim, Kian-Huat
    Amin, Manik A.
    Pedersen, Katrina
    Tan, Benjamin R.
    Huffman, Jess
    Lockhart, Albert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [10] The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
    Xu, Da
    Wang, Hongwei
    Bao, Quan
    Jin, Kemin
    Liu, Ming
    Liu, Wei
    Yan, Xiaoluan
    Wang, Lijun
    Zhang, Yanqiao
    Wang, Guangyu
    Ma, Yue
    Ma, Zhigang
    Zhang, Chunhui
    Tang, Jiebing
    Wang, Sha
    Pang, Jiaohui
    Xu, Ting
    Wang, Kun
    Xing, Baocai
    NATURE COMMUNICATIONS, 2025, 16 (01)
12345